aminoglutethimide has been researched along with suramin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Kelly, WK; Scher, HI; Steineck, G | 1 |
| Bergan, R; Brawley, OW; Cooper, MR; Dawson, N; Figg, WD; Headlee, D; Linehan, WM; Patronas, N; Reed, E; Sartor, O; Sausville, E; Senderowicz, A; Steinberg, SM; Sutherland, M | 1 |
1 review(s) available for aminoglutethimide and suramin
| Article | Year |
|---|---|
Hormone-refractory (D3) prostate cancer: refining the concept.
Topics: Aminoglutethimide; Clinical Trials as Topic; Cortisone; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Male; Medroxyprogesterone; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Suramin; Treatment Outcome | 1995 |
1 trial(s) available for aminoglutethimide and suramin
| Article | Year |
|---|---|
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Middle Aged; Prostatic Neoplasms; Suramin; Survival Rate | 1998 |
2 other study(ies) available for aminoglutethimide and suramin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |